VOLITIONRX LTD Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Volitionrx Ltd quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
  • Volitionrx Ltd Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.87M, a 32.2% increase year-over-year.
  • Volitionrx Ltd Operating Income (Loss) for the twelve months ending September 30, 2024 was -$30M, a 15% increase year-over-year.
  • Volitionrx Ltd annual Operating Income (Loss) for 2023 was -$36M, a 13.2% decline from 2022.
  • Volitionrx Ltd annual Operating Income (Loss) for 2022 was -$31.8M, a 12.2% decline from 2021.
  • Volitionrx Ltd annual Operating Income (Loss) for 2021 was -$28.3M, a 33.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$30M -$5.87M +$2.78M +32.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$32.8M -$6.99M +$2.56M +26.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$35.3M -$8.38M +$661K +7.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$36M -$8.74M -$730K -9.11% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$35.3M -$8.65M -$660K -8.26% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$34.6M -$9.55M -$1.45M -17.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$33.1M -$9.05M -$1.37M -17.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$31.8M -$8.01M +$774K +8.82% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$32.6M -$7.99M -$431K -5.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$32.1M -$8.1M -$2.2M -37.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$29.9M -$7.68M -$1.59M -26.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$28.3M -$8.79M -$3.13M -55.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$25.2M -$7.56M -$3.06M -67.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$22.1M -$5.9M -$688K -13.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$21.5M -$6.09M -$213K -3.63% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$21.2M -$5.66M -$1.93M -51.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$19.3M -$4.5M -$328K -7.86% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$19M -$5.21M -$1.06M -25.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$17.9M -$5.87M -$1.88M -47.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$16M -$3.72M +$530K +12.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$16.6M -$4.18M +$271K +6.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$16.8M -$4.15M +$412K +9.02% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$17.3M -$3.99M +$641K +13.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$17.9M -$4.26M -$215K -5.33% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 -$17.7M -$4.45M -$573K -14.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$17.1M -$4.57M -$1.12M -32.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$16M -$4.63M -$1.29M -38.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$14.7M -$4.04M -$557K -16% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$14.1M -$3.88M -$396K -11.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$13.7M -$3.44M -$467K -15.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$13.3M -$3.34M -$846K -33.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$12.4M -$3.48M -$812K -30.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$11.6M -$3.48M -$512K -17.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$11.1M -$2.98M -$958K -47.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$10.1M -$2.49M -$143K -6.08% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$10M -$2.67M -$771K -40.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$9.23M -$2.97M -$1.2M -68.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$8.03M -$2.02M -$967K -92.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$7.06M -$2.35M -$1.11M -89.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$5.95M -$1.9M -$205K -12.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$5.75M -$1.76M -$838K -90.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$4.91M -$1.05M -$2.95K -0.28% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$4.91M -$1.24M -$330K -36.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$4.58M -$1.7M -$218K -14.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-18
Q3 2013 -$4.36M -$926K -$53.1K -6.08% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$4.31M -$1.05M -$116K -12.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 -$4.19M -$908K -$106K -13.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$4.08M -$1.48M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 -$873K Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 -$931K Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 -$802K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.